Alza Corporation

Other

Acelrx Pharmaceuticals, Inc.

Alta Corporation

Evangeline Cruz

Patrick S Wong

Anthony L Kuczynski

Frank Jao

Eduardo C Sy

Noymi Yam

Padmanabh Bhatt

David E Edgren

Brenda J Pollock

Ryan Bronz

Tracy Fink

Alfredo M Wong

Carmelita Garcia

Sherry Li

Gregory Ruhlmann

Atul D Ayer

Stelios Tzannis

Larry Hamel

Nipun Davar

Adam Zhong

Ye Huang

Shamim Pushpala

Brenda Pollock

Gregory C Ruhlmann

Jayne Hastedt

Gemma Casadevall

Gaytri Sathyan

Linda Pors

Compositions and methods effective to minimize or eliminate the presence of oxidative degradation products in solid dosage forms comprising sufentanil are provided.

Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same

Aqueous drug coatings including at least one insoluble drug, wherein the insoluble drug accounts for about 85 wt % to about 97 wt % of the drug coatings are described. Such drug coatings may include only one insoluble drug, two or more insoluble drugs, or one or more insoluble drugs in combination with one or more soluble drugs.

Drug coating providing high drug loading

The present invention is directed to aqueous drug coatings that include at least one insoluble drug, wherein the drug accounts for about 85 wt % to about 97 wt % of the drug coatings. A drug coating according to the present invention may include only one insoluble drug, two or more insoluble drugs, or one or more insoluble drugs in combination with one or more soluble drugs. The present invention also includes drug coating formulations suitable for providing drug coatings according to the present invention and dosage forms that include a drug coating according to the present invention.

Drug coating providing high drug loading and methods for providing the same

Controlled release of active agents from sustained release push delivery devices having high drug loading are described wherein residual drug content in the device is minimized by the utilization of a flow-promoting layer between a semi-permeable wall and drug layer comprising the device.

Controlled delivery of active agents

Dosage forms and methods for the controlled release of antidepressives, such as exemplified by phenoxyethyl substituted-1,2,4-triazolones, as a suspension or a slurry over a prolonged period of time are described.

Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones

A dosage form is disclosed for delivering an antiepileptic drug, which dosage form comprises a laminated wall for maintaining the integrity of the dosage form and of the antiepileptic drug.

Dosage form comprising antiepileptic drug

A dosage form is disclosed for delivering an antiepileptic drug, which dosage form comprises for maintaining the integrity of the dosage form and of the antiepileptic drug.

Method for treating epilepsies

Effective therapy for epilepsies

Growing community of inventors

Hayward, CA, United States of America

Evangeline Cruz